Yeah, makes a lot of sense what your saying CG. Legal pro forma stuff. Despite my feelings yesterday, I see big positives: Epichem's growth is going gang busters, and I'm convinced that MPL/PPL-1 works in dogs (& likely therefore humans) as well as it works on long-suffering lab mice, I'm looking forward confidently towards the first ph 2 dog results in the very near future. At some point the public has got to sit up and take notice! The staff are experienced and world class. Cheers.
Ann: Prospectus, page-19
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $111.9M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 22.0¢ | $149.6K | 650.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 158933 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 9500 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |